A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma

Surgery (United States)

Volumn 159, Issue 3, 2016, Pages 842-851

  Saito, Hiroki ^a   Noji, Takehiro ^a   Okamura, Keisuke ^a   Tsuchikawa, Takahiro ^a   Shichinohe, Toshiaki ^a   Hirano, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PERIHILAR CHOLANGIOCARCINOMA; PLATELET LYMPHOCYTE RATIO; PORTAL VEIN; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PREOPERATIVE PROGNOSTIC SCORE; PRIORITY JOURNAL; PROSTATE CANCER PROGNOSTIC TEST; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE; VEIN EMBOLISM; VERY ELDERLY; BILE DUCT NEOPLASMS; BLOOD; CHOLANGIOCARCINOMA; COHORT ANALYSIS; DISEASE FREE SURVIVAL; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; JAPAN; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PATHOLOGY; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOMARKERS, TUMOR; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CHOLANGIOCARCINOMA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84960922921     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.10.027     Document Type: Article

References (47)

1. S. Kondo, S. Hirano, Y. Ambo, E. Tanaka, S. Okushiba, T. Morikawa, and et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study Ann Surg 240 2004 95 101
2. P. Neuhaus, S. Jonas, W.O. Bechstein, R. Lohmann, C. Radke, N. Kling, and et al. Extended resections for hilar cholangiocarcinoma Ann Surg 230 1999 808 818 discussion 19
3. M. Nagino, J. Kamiya, T. Arai, H. Nishio, T. Ebata, and Y. Nimura "Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma Ann Surg 243 2006 28 32
4. E. Hidalgo, S. Asthana, H. Nishio, J. Wyatt, G.J. Toogood, K.R. Prasad, and et al. Surgery for hilar cholangiocarcinoma: the Leeds experience Eur J Surg Oncol 34 2008 787 794
5. K. Matsuo, F.G. Rocha, K. Ito, M.I. D'Angelica, P.J. Allen, Y. Fong, and et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients J Am Coll Surg 215 2012 343 355
6. T.M. van Gulik, J.J. Kloek, A.T. Ruys, O.R. Busch, G.J. van Tienhoven, J.S. Lameris, and et al. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival Eur J Surg Oncol 37 2011 65 71
7. Y. Seyama, K. Kubota, K. Sano, T. Noie, T. Takayama, T. Kosuge, and et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate Ann Surg 238 2003 73 83
8. F. Ito, R. Agni, R.J. Rettammel, M.J. Been, C.S. Cho, D.M. Mahvi, and et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence Ann Surg 248 2008 273 279
9. A. Nanashima, Y. Sumida, T. Abo, T. Nagasaki, H. Takeshita, H. Fukuoka, and et al. Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy Hepatogastroenterology 54 2007 2337 2342
10. J.Y. Jang, S.W. Kim, D.J. Park, Y.J. Ahn, Y.S. Yoon, M.G. Choi, and et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection Ann Surg 241 2005 77 84
11. Y. Nimura, J. Kamiya, S. Kondo, M. Nagino, K. Uesaka, K. Oda, and et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience J Hepatobiliary Pancreat Surg 7 2000 155 162
12. Japanese Society of Biliary Surgery Classification of biliary tract carcinoma 2nd ed 2001 Kanehara Co., LTD. Tokyo
13. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474
14. T. Noji, M. Miyamoto, K.C. Kubota, T. Shinohara, Y. Ambo, Y. Matsuno, and et al. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer World J Surg Oncol 10 2012 106
15. A. Yonemori, S. Kondo, Y. Matsuno, T. Ito, Y. Nakanishi, M. Miyamoto, and et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer Ann Surg 252 2010 99 106
16. A. Yonemori, S. Kondo, Y. Matsuno, T. Ito, E. Tanaka, and S. Hirano Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer Br J Surg 96 2009 509 516
17. T. Noji, S. Kondo, S. Hirano, E. Tanaka, Y. Ambo, Y. Kawarada, and et al. CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer J Gastroenterol 40 2005 739 743
18. T. Noji, S. Kondo, S. Hirano, E. Tanaka, O. Suzuki, and T. Shichinohe Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer Br J Surg 95 2008 92 96
19. D. Gomez, G. Morris-Stiff, G.J. Toogood, J.P. Lodge, and K.R. Prasad Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma J Surg Oncol 97 2008 513 518
20. S.R. Walsh, E.J. Cook, F. Goulder, T.A. Justin, and N.J. Keeling Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181 184
21. R.A. Smith, L. Bosonnet, M. Raraty, R. Sutton, J.P. Neoptolemos, F. Campbell, and et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma Am J Surg 197 2009 466 472
22. A. Riesco Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils Cancer 25 1970 135 140
23. L.M. Forrest, D.C. McMillan, C.S. McArdle, W.J. Angerson, and D.J. Dunlop Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer Br J Cancer 89 2003 1028 1030
24. Y. Kishi, S. Kopetz, Y.S. Chun, M. Palavecino, E.K. Abdalla, and J.N. Vauthey Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy Ann Surg Oncol 16 2009 614 622
25. K.J. Halazun, A. Aldoori, H.Z. Malik, A. Al-Mukhtar, K.R. Prasad, G.J. Toogood, and et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases Eur J Surg Oncol 34 2008 55 60
26. D. Gomez, S. Farid, H.Z. Malik, A.L. Young, G.J. Toogood, J.P. Lodge, and et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 2008 1757 1762
27. F. Salazar-Onfray, M.N. Lopez, and A. Mendoza-Naranjo Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape Cytokine Growth Factor Rev 18 2007 171 182
28. F. Romano, F. Uggeri, S. Crippa, G. Di Stefano, M. Scotti, A. Scaini, and et al. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers J Exp Clin Cancer Res 23 2004 195 200
29. M.H. Klinger, and W. Jelkmann Role of blood platelets in infection and inflammation J Interferon Cytokine Res 22 2002 913 922
30. M.G. Alexandrakis, F.H. Passam, I.A. Moschandrea, A.V. Christophoridou, C.A. Pappa, S.A. Coulocheri, and et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis Am J Clin Oncol 26 2003 135 140
31. E.G. Kandemir, A. Mayadagli, B. Karagoz, O. Bilgi, O. Turken, and M. Yaylaci Prognostic significance of thrombocytosis in node-negative colon cancer J Int Med Res 33 2005 228 235
32. M. Ikeda, H. Furukawa, H. Imamura, J. Shimizu, H. Ishida, S. Masutani, and et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer Ann Surg Oncol 9 2002 287 291
33. H. Shimada, G. Oohira, S. Okazumi, H. Matsubara, Y. Nabeya, H. Hayashi, and et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma J Am Coll Surg 198 2004 737 741
34. T. Dumitrascu, D. Chirita, M. Ionescu, and I. Popescu Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome J Gastrointest Surg 17 2013 913 924
35. H. Bismuth, R. Nakache, and T. Diamond Management strategies in resection for hilar cholangiocarcinoma Ann Surg 215 1992 31 38
36. P.A. Clavien, J. Barkun, M.L. de Oliveira, J.N. Vauthey, D. Dindo, R.D. Schulick, and et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
37. T. Gerhardt, S. Milz, M. Schepke, G. Feldmann, M. Wolff, T. Sauerbruch, and et al. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma World J Gastroenterol 12 2006 5495 5500
38. K. Hirohashi, T. Uenishi, S. Kubo, T. Yamamoto, H. Tanaka, T. Shuto, and et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes Hepatogastroenterology 49 2002 326 329
39. B. Juntermanns, S. Radunz, M. Heuer, S. Hertel, H. Reis, J.P. Neuhaus, and et al. Tumor markers as a diagnostic key for hilar cholangiocarcinoma Eur J Med Res 15 2010 357 361
40. T. Sano, K. Shimada, Y. Sakamoto, H. Ojima, M. Esaki, and T. Kosuge Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus Ann Surg Oncol 15 2008 590 599
41. H.Z. Malik, K.R. Prasad, K.J. Halazun, A. Aldoori, A. Al-Mukhtar, D. Gomez, and et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases Ann Surg 246 2007 806 814
42. A.R. Hakeem, G. Marangoni, S.J. Chapman, R.S. Young, A. Nair, E.L. Hidalgo, and et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol 26 2014 1047 1054
43. J.V. Castell, M.J. Gomez-Lechon, M. David, R. Fabra, R. Trullenque, and P.C. Heinrich Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6 Hepatology 12 1990 1179 1186
44. K. Okuda Growth and survival in small hepatocellular carcinoma HPB Surg 7 1994 254 257
45. J. Park, L. Tadlock, G.J. Gores, and T. Patel Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line Hepatology 30 1999 1128 1133
46. F. Meng, R. Henson, M. Lang, H. Wehbe, S. Maheshwari, J.T. Mendell, and et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines Gastroenterology 130 2006 2113 2129
47. J.S. Goydos, A.M. Brumfield, E. Frezza, A. Booth, M.T. Lotze, and S.E. Carty Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker Ann Surg 227 1998 398 404